title: Hyperalgesia and edema responses induced by rat peripheral blood mononuclear cells incubated with carrageenin.
abstract: The aim of this study was to verify the role played by mononuclear cells in an acute (nonimmune) inflammatory reaction. Mononuclear cells purified from rat peripheral blood were incubated for 1, 2, or 24 h with 100 or 250 microg/ml carrageenin (Cg). The resultant donor supernatant was injected into recipient rats to test its ability to induce hyperalgesia (reduction in threshold for paw pressure) and edema (increase in paw volume). Mononuclear cell supernatants (MnS) induced a significant time- and dose-dependent hyperalgesia and edema in rat paws, which reached a maximal effect at 3 h, lasted for 6 h, and returned to basal levels at 24 h of injection. Prostaglandins and cytokines (interleukin 1, 2, 6, 8, and tumor necrosis factor alpha) accounted for the hyperalgesia induced by MnS, as it was reduced (40 to 90%) by synthesis inhibitors such as indomethacin, dexamethasone, rolipram, and cyclosporin added to the cultures at a microgram dose-range. Edema was dependent on serotonin release in rat paws. These results indicate that mononuclear cells may be important contributors to acute inflammatory reactions, especially under those conditions where pain is an important component.
authors.affiliation: Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
authors.forename: M A
authors.initials: MA
authors.lastname: De Resende
authors.forename: W G
authors.initials: WG
authors.lastname: Pimenta Dos Rei
authors.forename: L S
authors.initials: LS
authors.lastname: Pereira
authors.forename: W
authors.initials: W
authors.lastname: Ferreira
authors.forename: M H
authors.initials: MH
authors.lastname: Perez Garcia
authors.forename: M M
authors.initials: MM
authors.lastname: Santoro
authors.forename: J
authors.initials: J
authors.lastname: Nogueira de Francischi
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D002351:Carrageenan; D017077:Culture Media, Conditioned / Q000737:chemistry / Q000494:pharmacology; D016207:Cytokines / Q000502:physiology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D005260:Female; D006930:Hyperalgesia / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D007249:Inflammation / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D007700:Kinetics; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D011453:Prostaglandins / Q000502:physiology; D051381:Rats; D012701:Serotonin / Q000502:physiology
chemical_list: D000893:Anti-Inflammatory Agents; D017077:Culture Media, Conditioned; D016207:Cytokines; D011453:Prostaglandins; D012701:Serotonin; D002351:Carrageenan